Conditionally immortalized colonic epithelial cell line from a Ptk6 null mouse that polarizes and differentiates in vitro

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 7 PT1, 2008, Pages 1119-1124

  Whitehead, Robert H ^a,b   Robinson, Pamela S ^b   Williams, Janice A ^a   Bie, Wenjun ^c   Tyner, Angela L ^c   Franklin, Jeffrey L ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b Vanderbilt Digestive Disease Research Center   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Conditional immortalization; Differentiation; Epithelium; Mouse colon; Tissue culture

Indexed keywords

CHROMOGRANIN A; OCCLUDIN; PROTEIN ZO1; VILLIN;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL IMMORTALIZATION; CELL LINE; CELL POLARITY; COLON MUCOSA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; GENOTYPE; GOBLET CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE MUCOSA; MONOLAYER CULTURE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIMIAN VIRUS 40; STEM CELL; TIGHT JUNCTION; TISSUE CULTURE; TRANSGENIC MOUSE;

EID: 47649087707     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05308.x     Document Type: Article

References (20)

1. Perreault N, Beaulieu J-F. Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp. Cell Res. 1996 224 : 354 64.
2. Perreault N, Beaulieu JF. Primary culture of fully differentiated and pure human intestinal epithelial cells. Exp. Cell Res. 1998 245 : 34 42.
3. Quaroni A, Beaulieu J-F. Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells. Gastroenterology 1997 113 : 1198 213.
4. Kirkland SC. Endocrine differentiation by a human rectal adenocarcinoma cell line (HRA-19). Differentiation 1986 33 : 148 55.
5. Rousset M. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 1986 68 : 1035 40.
6. Tanaka Y, Bush KK, Klauck TM, Higgins PJ. Enhancement of butyrate-induced differentiation of HT-29 colon carcinoma cells by 1,25-dihydroxyvitamin D3. Biochem. Pharmacol. 1989 38 : 3859 65.
7. Whitehead RH, Zhang HH, Hayward IP. Characterisation of a panel of colon carcinoma cell lines using tissue-specific markers. Immunol. Cell Biol. 1992 70 : 227 36.
8. Jat PS, Noble MD, Ataliotis P et al. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl Acad. Sci. USA 1991 88 : 5096 100.
9. Whitehead RH, Joseph JL. Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonic mucosa and other tissues of F1 mouse (Immortomouse/Min). Epithelial Cell Biol. 1994 3 : 119 25.
10. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. The establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl Acad. Sci. USA 1993 90 : 587 91.
11. Haegebarth A, Bie W, Yang R et al. Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the mouse. Mol. Cell Biol. 2006 26 : 4949 57.
12. Barker KT, Jackson LE, Crompton MR. Brk tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 1997 15 : 799 805.
13. Kirkland SC. Dome formation by a human colonic adenocarcinoma cell line (HCA7). Cancer Res. 1985 45 : 3790 5.
14. Whitehead RH, Jones JK, Gabriel A, Lukies RE. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. Cancer Res. 1987 47 : 2683 9.
15. Pageot L-P, Perreault N, Basora N, Francoeur C, Magny P, Beaulieu J-F. Human cell models to study small intestinal functions: recapitulation of the crypt-villus axis. Microsc. Res. Techn. 2000 49 : 394 406.
16. Celano P, Berchtold CM, Mabry M et al. Induction of markers of normal differentiation in colon carcinoma cells by v-ras-H. Cell Growth Differ. 1993 4 : 341 7.
17. Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH. Brk activates rac1 and promotes cell migration. Mol. Cell Biol. 2004 24 : 10 58 72.
18. Llor X, Serfas MS, Bie W et al. Brk/Sik expression in the gastrointestinal tract and in the colon. Clin. Cancer Res. 1999 5 : 1767 77.
19. Harvey AJ, Crompton MR. The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges. Anticancer Drugs 2004 15 : 107 11.
20. Haegebarth A, Nunez R, Tyner AL. The intracellular tyrosine kinase Berk sensitizes non-transformed cells to inducers of apoptosis. Cell Cycle 2005 4 : 1239 46.